|
NSUN3 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.012250E-04 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.401400E-03 |
| Normal-vs-Stage2 |
4.16810000003487E-06 |
| Normal-vs-Stage3 |
2.3631000000135E-06 |
| Normal-vs-Stage4 |
1.611640E-04 |
| Stage1-vs-Stage2 |
1.152110E-02 |
| Stage1-vs-Stage3 |
5.944300E-03 |
| Stage1-vs-Stage4 |
9.946500E-02 |
| Stage2-vs-Stage3 |
6.385200E-01 |
| Stage2-vs-Stage4 |
2.370600E-01 |
| Stage3-vs-Stage4 |
4.008200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.771740E-04 |
| Normal-vs-AfricanAmerican |
1.471970E-01 |
| Normal-vs-Asian |
5.441800E-03 |
| Caucasian-vs-AfricanAmerican |
2.744200E-01 |
| Caucasian-vs-Asian |
6.201800E-01 |
| AfricanAmerican-vs-Asian |
4.853200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.77050000011492E-07 |
| Normal-vs-Female |
8.807700E-04 |
| Male-vs-Female |
2.907800E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.157600E-02 |
| Normal-vs-Age(41-60Yrs) |
7.91100000000489E-05 |
| Normal-vs-Age(61-80Yrs) |
7.57819999974707E-07 |
| Normal-vs-Age(81-100Yrs) |
1.977980E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.394200E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.481220E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.051700E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.907160E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.640400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.912200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.611200E-01 |
| Classical-VS-Follicular |
3.034700E-04 |
| Classical-VS-Other |
7.275600E-01 |
| Classical-VS-Normal |
4.518000E-03 |
| Tall-VS-Follicular |
1.892040E-01 |
| Tall-VS-Other |
8.031600E-01 |
| Tall-VS-Normal |
2.382900E-03 |
| Follicular-VS-Other |
4.273800E-01 |
| Follicular-VS-Normal |
2.04849999996259E-06 |
| Other-VS-Normal |
1.368360E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.31200000000431E-06 |
| Normal-vs-N1 |
2.581700E-03 |
| N0-vs-N1 |
4.873600E-01 |
|
|
